Complement activation in cisplatin nephropathy.
Tamano
M
M
Ohi
H
H
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002945:Cisplatin / Q000009:adverse effects* / Q000627:therapeutic use; D003167:Complement Activation / Q000187:drug effects*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000473:pathology; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male
D000970:Antineoplastic Agents; D002945:Cisplatin